---
figid: PMC9077075__ajcr0012-1686-f6
pmcid: PMC9077075
image_filename: ajcr0012-1686-f6.jpg
figure_link: /pmc/articles/PMC9077075/figure/fig06/
number: Figure 6
figure_title: ''
caption: Time- and dose-dependent effects of anti-tumor drugs on tumor tumorsphere
  viability. A. Time course of ES2 and ES2TR160 tumorsphere (TS) proliferation in
  the absence or presence of different doses of paclitaxel or RAD001. B. The percentage
  of proliferation in ES2 and ES2TR160 tumorspheres when treated with the IC50 of
  RAD001 followed by different concentrations of 5-aza-2-dC (0, 0.1, 1, 10, 100 μM).
  (*P<0.05, **P<0.01, ***P<0.001, all by students’ t-test).
article_title: Everolimus combined with 5-aza-2-deoxycytidine generated potent anti-tumor
  effects on ovarian clear cell cancer stem-like/spheroid cells by inhibiting the
  COL6A3-AKT-mTOR pathway.
citation: Chih-Ming Ho, et al. Am J Cancer Res. 2022;12(4):1686-1706.
year: '2022'

doi: ''
journal_title: American Journal of Cancer Research
journal_nlm_ta: Am J Cancer Res
publisher_name: e-Century Publishing Corporation

keywords:
- 5-aza-2-deoxycytidine
- everolimus
- ovarian cancer
- ovarian clear cell
- cancer stem cells
- COL6A3-AKT-mTOR pathway

---
